Sweet syndrome: a case report and literature review
DOI:
https://doi.org/10.29176/2590843X.12Keywords:
Sweet's syndrome, granulocyte colony-stimulating factor, histiocytesAbstract
Histiocytoid Sweet syndrome is a rare variant of the acute febrile neutrophilic dermatosis (Sweet syndrome) which was first described in 2005 by Requena, et al., and is characterized by inflammatory infiltrate composed of immature myeloid cells similar to histiocytes.
Clinically it is similar to the classical variant and is associated with underlying conditions such as autoimmune diseases and hematological malignancies.
It has shown a relationship with the consumption of certain drugs, mainly granulocyte colony-stimulating factor and some antimicrobial drugs such as trimethoprim-sulfamethoxazole. It has an adequate therapeutic response to corticosteroids and has a generally benign course with low risk of recurrence.
Author Biographies
Laura Carolina Camacho, Hospital Pablo Tobón Uribe
Médica general, Hospital Pablo Tobón Uribe, Medellín, Colombia.
Delsy Del Río, Hospital Pablo Tobón Uribe
Médica dermatóloga, Hospital Pablo Tobón Uribe, Medellín, Colombia
Ana Cristina Ruiz, Hospital Pablo Tobón Uribe
Medica dermatopatóloga, Hospital Pablo Tobón Uribe, Medellín, Colombia
References
Wu A, Rodgers T, Fullen D. Drug-associated histiocytoid Sweet’s syndrome: a true neutrophilic maturation arrest variant. J Cutan Pathol. 2008; 35: 220-224.
Peroni A, Colato C, Schena D, Rongioletti F, Girolomoni G. Histiocyted Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol. 2015; 72: 131-138.
Rodríguez L, Di Martino – Ortiz B, Lezcano L, Rodríguez – Masi M, Knopfelmacher O, Bolla – de Lezcano L. Sindrome de Sweet descripción de un caso idiopático. Dermatología Peruana. 2012; vol 23 (2): 113-116.
Cohen P. Sweet ́s syndrome – a comprenhensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007; 2: 1- 28.
Franco M, Guisti C, Malieni D, Ferrairo D, Galimberti G, Hidalgo I, Kowalczuk A, Galimberti R. Sindrome de Sweet asociado a neoplasias. An Bras Dermatol. 2006; 81 (5): 473-482.
Apalla Z, Kanati L, Sortiriou E, Manousari A, Papagarifallou I, Calonje E. Histiocytoid Sweet syndrome. Clin Exp Dermatol. 2011; 36: 562-563.
Serap B, Ayse K, Omer C, Gulay B. Histiocytoid Sweet syndrome. Int J Dermatol. 2014; 53: 80- 82.
Requena L, Kutzner H, Palmedo G, Pascual M, Fernandez-Herrera J, Fraga J, et al. Histiocytoid Sweet sindrome: a dermal infiltration of inmature neutrophilic granulocytes. Arch Dermatol. 2005; 141: 834-842.
Llamas-Velasco M, Concha- Garzón M, Fraga J, Argüés M. Histiocytoid Sweet syndrome related to bortezomib: A mimicker of cutaneous infiltration by myeloma. Indian Dermatol Online J. 2015; 81: 305- 306.E.Rev Asoc Colomb Dermatol. 2017; 25: 2 (abril-junio), 154-159Camacho, LC; Del Río, D; Ruiz, AC
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
